Abstract

Introduction: Clostridioides (Clostridium) difficile can be isolated from stool in 3% of healthy adults and in at least 10% of asymptomatic hospitalized patients. C. difficile, the most common cause of hospital-acquired infectious diarrhea in the developed world, has re-emerged in recent years with increasing incidence and severity. In an effort to reduce the spread of the pathogen, published recommendations suggest isolation and contact precautions for patients suffering from C. difficile infection (CDI). However, asymptomatic colonized patients are not targeted by infection control policies, and active surveillance for colonization is not routinely performed. Moreover, given the current changes in the epidemiology of CDI, particularly the emergence of new virulent strains either in the hospital or community settings, there is a need for identification of factors associated with colonization by C. difficile and CDI. Methods and analysis: We are carrying out a prospective, observational, cohort study in Edouard Herriot Hospital, Hospices Civils de Lyon, a 900-bed university hospital in Lyon, France. All consecutive adult patients admitted on selected units are eligible to participate in the study. Stool samples or rectal swabs for C. difficile testing are obtained on admission, every 3–5 days during hospitalization, at the onset of diarrhea (if applicable), and at discharge. Descriptive and logistic regression analyses will be completed to mainly estimate the proportion of asymptomatic colonization at admission, and to evaluate differences between factors associated with colonization and those related to CDI. Ethics: The study is conducted in accordance with the ethical principles of the Declaration of Helsinki, French law, and the Good Clinical Practice guidelines. The study protocol design was approved by the participating units, the ethics committee and the hospital institutional review board (Comité de protection des personnes et Comission Nationale de l’Informatique et des Libertés; N°: 00009118). Dissemination: The results of this study will be disseminated by presenting the findings locally at each participating ward, as well as national and international scientific meetings. Findings will be shared with interested national societies crafting guidelines in CDI.

Highlights

  • Clostridioides (Clostridium) difficile can be isolated from stool in 3% of healthy adults and in at least 10% of asymptomatic hospitalized patients

  • C. difficile can be isolated from stool in 3% of healthy adults and in at least 10% of asymptomatic hospitalized patients

  • An investigation to compare the burden of environmental shedding of toxigenic C. difficile among asymptomatic carriers, C. difficile infection (CDI) patients and non-carriers in non-epidemic settings showed more than residual contamination in 41% of carrier rooms—24% of these were heavily contaminated

Read more

Summary

Introduction

Clostridioides (Clostridium) difficile can be isolated from stool in 3% of healthy adults and in at least 10% of asymptomatic hospitalized patients. All consecutive adult patients admitted on selected units are eligible to participate in the study. C. difficile can be isolated from stool in 3% of healthy adults and in at least 10% of asymptomatic hospitalized patients. It is widely distributed in soil and in the intestinal tracts of animals [1]. The clinical spectrum of C. difficile infection (CDI) varies in severity from asymptomatic carriage and self-limited mild, watery diarrhea, to pseudomembranous colitis (PMC), intestinal perforation, toxic megacolon, sepsis, fulminant colitis, and death [3]. Its impact in healthcare settings is considerable, in terms of morbidity, mortality and financial cost [12]

Objectives
Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call